What is SJIA?
SJIA is a type of juvenile arthritis that has no apparent cause and affects children aged 16 years and younger. It can be caused by too much interleukin 1 beta (IL-1β) in the body. This can lead to inflammation. Like other forms of juvenile idiopathic arthritis, SJIA involves swelling in one or more joints lasting at least six weeks. However, SJIA also presents with systemic symptoms affecting the whole body, beyond the joints. These symptoms include spiking fevers that come and go and may precede swollen joints.
Images are not actual patients.
What is the difference between a localized and a systemic symptom?
Instead of localized symptoms, such as pain in certain joints, systemic symptoms can affect the body as a whole. For example, a systemic symptom of SJIA is fever.
Why do children get SJIA?
SJIA is idiopathic, which means that no one knows for sure what causes SJIA. It is not passed down to the child, and it occurs equally in males and females. Learn more about your child and SJIA.
What will happen to my child with SJIA?
The course of SJIA varies from child to child. The disease cycle swings back and forth between symptom-free periods to flares, or times when the symptoms worsen. Some children with SJIA only get one cycle of symptoms, and others will have a chronic course of ups and downs. Learn about SJIA treatment options.
What is ILARIS?
ILARIS is a prescription medication that is FDA approved to treat active SJIA. ILARIS works by attaching to and blocking interleukin-1β (IL-1β), a type of cytokine responsible for inflammation. ILARIS is given once a month as a subcutaneous injection right below the skin.
How can ILARIS help with active SJIA?
ILARIS provides fast relief (by day 15) from active SJIA symptoms, improving arthritic symptoms such as painful and/or swollen joints, and systemic symptoms such as fever. In addition, as shown in a clinical study some children receiving ILARIS were able to reduce or stop taking corticosteroids altogether. Talk to your doctor to find out if ILARIS is a treatment option for your child.
How fast does ILARIS work?
In a clinical study fifteen days after their first dose of ILARIS, approximately 8 of 10 children taking ILARIS experienced improvement in active SJIA symptoms such as fever and painful and/or swollen joints. None of the children taking ILARIS had fever by day 3 after the first dose.
Is ILARIS given intravenously?
ILARIS is not given as an intravenous infusion (infused inside a vein over a period of 1 or 2 hours). Instead, it is given as a subcutaneous (right under the skin) injection, or shot, once a month by a doctor or nurse.
A home health nurse can be sent to your home to administer ILARIS to your child. If you are eligible, this service and other ILARIS support opportunities may be available for your child.
Is support available to help pay for ILARIS?
The ILARIS Support Program offers a full range of services to assist in the management of ILARIS therapy, such as:
To whom can I speak to if I have more questions about ILARIS?
If you have questions about the ILARIS Support Program, please call toll-free at 866-972-8315.
ILARIS® (canakinumab) is a prescription medicine injected by your healthcare provider just below the skin (subcutaneous) used to treat:
IMPORTANT SAFETY INFORMATION
ILARIS can cause serious side effects, including increased risk of serious infections. ILARIS can lower the ability of your immune system to fight infections. Your healthcare provider should:
Tell your healthcare provider right away if you have any symptoms of an infection such as fever, sweats or chills, cough, flu-like symptoms, weight loss, shortness of breath, blood in your phlegm, sores on your body, warm or painful areas on your body, diarrhea or stomach pain, or feeling very tired.
You should not receive ILARIS if you are allergic to canakinumab or any of the ingredients in ILARIS.
Before receiving ILARIS, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take:
Ask your healthcare provider if you are not sure.
ILARIS can cause serious side effects including:
The most common side effects of ILARIS when used for the treatment of CAPS include: cold symptoms, diarrhea, flu (influenza), runny nose, headache, cough, body aches, nausea, vomiting, and diarrhea (gastroenteritis), feeling like you are spinning (vertigo), weight gain, injection site reactions (such as redness, swelling, warmth, or itching), and nausea.
The most common side effects of ILARIS when used for the treatment of TRAPS, HIDS/MKD, and FMF: cold symptoms, upper respiratory tract infection, runny nose, sore throat, nausea, vomiting, and diarrhea (gastroenteritis), and injection site reactions (such as redness, swelling, warmth, or itching)
The most common side effects of ILARIS when used for the treatment of SJIA include: cold symptoms, upper respiratory tract infection, pneumonia, runny nose, sore throat, urinary tract infection, nausea, vomiting and diarrhea (gastroenteritis), stomach pain, and injection site reactions (such as redness, swelling, warmth, or itching)
Tell your healthcare provider about any side effect that bothers you or does not go away.
What is Macrophage Activation Syndrome (MAS)?
MAS is a syndrome associated with SJIA and some other auto-inflammatory diseases like HIDS/MKD that can lead to death. Tell your healthcare provider right away if your SJIA symptoms get worse or if you have any of these symptoms of an infection:
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
All trademarks are the property of their respective owners.
Symptoms: a description of the way you are feeling due to an illness.
Arthritis: inflammation of one or more joints, which can cause pain, swelling, stiffness, and loss of motion.
Inflammation: the body's protective response that results in heat, pain, redness, and swelling.
Juvenile Arthritis (JA): a medical condition that occurs in children before age 16 and involves swelling in one or more joints lasting at least 6 weeks.
Systemic Juvenile Idiopathic Arthritis (SJIA): a type of arthritis that has no apparent cause and affects children aged 16 years and younger. Like other forms of juvenile idiopathic arthritis, SJIA involves swelling in one or more joints lasting at least 6 weeks. However, SJIA affects the whole body, beyond the joints. It is characterized by spiking fevers that come and go and a pink or salmon-colored rash, both of which may precede swollen joints.
Idiopathic: the exact cause of the disease is unknown.
Autoinflammatory disease: an illness in which the body's control of inflammation is not functioning properly, leading to uncontrolled inflammation.
Pediatric rheumatologist: a doctor who specializes in diagnosing and treating bone and joint disorders in children and teenagers.
Systemic: affecting the entire body, rather than a single organ or body part.
Flare: the worsening and increase in severity of disease symptoms.
Biologic: a product made from living cells that is used to treat diseases. Biologics are genetically engineered proteins derived from human genes.
Cytokine: a protein produced by the body that interacts with the cells of the immune system to help fight infection. When the body produces too many cytokines, it can cause inflammation and tissue destruction.
Injection: usually referred to as "a shot," an injection puts medication into the body using a syringe.
Cryopyrin-Associated Periodic Syndromes: a group of rare and genetic diseases that includes Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS).
Genetic: of or relating to the genes or heredity, meaning it can be passed down in families.
Disease: a condition of a body part, organ, or system that occurs due to genetics, infection, or the environment and that typically presents with a specific group of symptoms.
Familial Cold Autoinflammatory Syndrome: an autoinflammatory disease in a group of rare diseases called Cryopyrin-Associated Periodic Syndromes (CAPS). It is also known as FCAS.
Inflammation: the body's way of protecting itself against infection or injury. When someone has the condition called Cryopyrin-Associated Periodic Syndromes (CAPS), inflammation occurs without infection or injury.
IL-1β: a protein that the immune system produces to fight disease with inflammation. The production of too much IL-1▀ is harmful to the body. IL-1β is also called interleukin-1 beta.
Immune system: the body's natural defense system that protects against any material foreign to the body.
Muckle-Wells Syndrome: an autoinflammatory disease in a group of rare diseases called Cryopyrin-Associated Periodic Syndromes (CAPS). It is also known as MWS.
Rare disease: an uncommon illness that affects very few people.
Conjunctivitis: Also called pink eye, conjunctivitis is redness and inflammation of the whites of the eyes and eyelids. There are many causes of conjunctivitis, including Familial Cold Autoinflammatory Syndrome and Muckle-Wells Syndrome.